I have spoken to several brokers in the past who frankly don’t rate MSB
I think MSB’s reputation is causing this mis-pricing opportunity which some nimble buyers could definitely take advantage of
Shorters don’t have the monopoly on knowledge every time with them obviously punting on a rejection of the application ….just look at LTR a few months ago when it gapped up nearly $2 on receipt of a takeover
- Forums
- ASX - By Stock
- MSB
- 2023 The Final Countdown
2023 The Final Countdown, page-2079
-
- There are more pages in this discussion • 1,325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.618M | 1.381M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 18060 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 16015 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 44140 | 1.175 |
13 | 102517 | 1.170 |
14 | 120595 | 1.165 |
10 | 97349 | 1.160 |
8 | 64460 | 1.155 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 27451 | 8 |
1.185 | 43161 | 11 |
1.190 | 219953 | 18 |
1.195 | 100133 | 11 |
1.200 | 92010 | 15 |
Last trade - 11.21am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online